Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:40 PM UTC
| NCT Number | NCT06510374 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE3 |
| Target Enrollment | 454 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Ferring Pharmaceuticals |
| Last Updated on CT.gov | July 10, 2026 (6 days ago) |
As of July 16, 2026: Clinical trial NCT06510374 is currently recruiting participants. This phase3 study for bladder cancer is actively seeking new participants at 51 locations across the United States. The study is sponsored by Ferring Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06510374 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06510374 was last updated 6 days ago (July 10, 2026). HelloStudys verifies this status automatically.